Table 1.
The baseline clinical and pathological information of patients from the two groups in the discovery cohort.
| Variables | Total (n = 204) | Low-risk (n = 102) | High-risk (n = 102) | P-value |
|---|---|---|---|---|
| Age | 61 (55–63) | I61 (56–63) | 60 (54–63) | 0.389 |
| Sex | ||||
| Female | 109 (53%) | 63 (62%) | 46 (45%) | 0.025 |
| Male | 95 (47%) | 39 (38%) | 56 (55%) | |
| Smoking | ||||
| No | 105 (51%) | 63 (62%) | 42 (41%) | 0.005 |
| Yes | 99 (49%) | 39 (38%) | 60 (59%) | |
| Pathological stage | ||||
| Stage I | 162 (79%) | 96 (94%) | 66 (65%) | <0.001 |
| Stage II | 42 (21%) | 6 (6%) | 36 (35%) | <0.001 |